US Stocks Mixed; Jobless Claims Fall To 202,000

U.S. stocks traded mixed this morning, with the Dow Jones index gaining around 50 points on Thursday. Following the market opening Thursday, the Dow traded up 0.15% to 37,487.49 while the NASDAQ fell 0.27% to 14,553.12. The S&P 500 also fell, dropping, 0.01% to 4,704.42.

U.S. stocks traded mixed this morning, with the Dow Jones index gaining around 50 points on Thursday.

Following the market opening Thursday, the Dow traded up 0.15% to 37,487.49 while the NASDAQ fell 0.27% to 14,553.12. The S&P 500 also fell, dropping, 0.01% to 4,704.42.

Check This Out: How To Earn $500 A Month From Constellation Brands Stock Ahead Of Q3 Earnings Report

 

Leading and Lagging Sectors

 

Energy shares rose by 0.7% on Thursday.

In trading on Thursday, consumer discretionary shares fell by 0.6%.

 

Top Headline

 

U.S. initial jobless claims fell by 18,000 to 202,000 in the final week of 2023, compared to market estimates of 216,000.

 

Equities Trading UP

 

Minim, Inc. (NASDAQ:MINM) shares shot up 186% to $4.88.

Shares of Omega Therapeutics, Inc. (NASDAQ:OMGA) got a boost, surging 108% to $5.67 after Novo Nordisk entered into a research collaboration with the company.

Avenue Therapeutics, Inc. (NASDAQ:ATXI) shares were also up, gaining 48% to $0.2598 after the company announced it reached a final agreement with the FDA for the Phase 3 safety study for IV tramadol.

 

Equities Trading DOWN

 

SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) shares dropped 33% to $0.6097 after the company announced pricing of $9.0 million public offering.

Shares of Mobileye Global Inc. (NASDAQ:MBLY) were down 26% to $29.40 after the company issued preliminary FY23 financial results and initial 2024 guidance.

E-Home Household Service Holdings Limited (NASDAQ:EJH) was down, falling 28% to $1.07.

Also Check This Out: Jim Cramer: This Energy Firm Has ‘Good Growth, Good Yield’ But As For IonQ? Ixnay

 

Commodities

 

In commodity news, oil traded up 0.7% to $73.17 while gold traded up 0.2% at $2,046.30.

Silver traded down 0.6% to $23.02 on Thursday while copper fell 0.8% to $3.83.

 

Euro zone

 

European shares were mostly higher today. The eurozone’s STOXX 600 rose 0.1%, London’s FTSE 100 rose 0.2% while Spain’s IBEX 35 Index rose 0.7% The German DAX fell 0.1% French CAC 40 rose 0.1% while Italy’s FTSE MIB Index gained 0.3%.

The HCOB Eurozone services PMI was revised higher to 48.8 in December versus a preliminary reading of 48.1. The HCOB France services PMI climbed to 45.7 in December, recording the highest reading in four months, while German services PMI rose to 49.3 in December versus a preliminary estimate of 48.4.

The S&P Global/CIPS UK services PMI increased to 53.4 in December from 50.9 in the prior month. Consumer credit in the UK rose by £2.005 billion in November versus a revised £1.3411 billion in the previous month.

 

Asia Pacific Markets

 

Asian markets closed mostly lower on Thursday, with Japan’s Nikkei 225 falling 0.53%, Hong Kong’s Hang Seng Index falling 0.01% and China’s Shanghai Composite Index falling 0.43%. India’s S&P BSE Sensex, meanwhile, rose 0.67%.

The Caixin China General Service PMI rose to 52.9 in December from 51.5 a month ago, while S&P Global Hong Kong SAR PMI climbed to 51.3 in December versus 50.1 in November. The au Jibun Bank Japan Manufacturing PMI rose to 47.9 in December versus a flash reading of 47.7.

 

Economics

 

U.S.-based employers announced plans to reduce 34,817 jobs in December.

Private businesses in the U.S. added 164,000 workers in December versus a revised 101,000 gain in November and topping market estimates of 115,000.

U.S. initial jobless claims fell by 18,000 to 202,000 in the final week of 2023, compared to market estimates of 216,000.

Now Read This: Wall Street’s Most Accurate Analysts Say Buy These 3 Energy Stocks Delivering High-Dividend Yields

Total
0
Shares
Related Posts
Read More

Drugs for Neglected Diseases Initiative and Sanofi Announced Treatment Success Rates of Up to 95% From a Phase II/II Study Investigating the Safety and Efficacy of Single-dose Acoziborole for Sleeping Sickness

The Drugs for Neglected Diseases initiative (DNDi) and Sanofi announce treatment success rates of up to 95% from a Phase II/III study investigating the safety and efficacy of single-dose acoziborole, a potentially transformative investigational treatment for sleeping sickness, published today in The Lancet Infectious Diseases medical journal.

SNY

Read More

Why Dermata Therapeutics Shares Are Trading Higher By Over 57%; Here Are 20 Stocks Moving Premarket

Shares of Dermata Therapeutics, Inc. (NASDAQ: DRMA) rose sharply in pre-market trading after the company announced the issuance of a new patent in Japan for its DMT410 program for the treatment of hyperhidrosis. Dermata Therapeutics shares jumped 57.3% to $0.9601 in pre-market trading.

AIMD